FFCP PHASE1:Mm9::chr14:56503087..56503092,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=56410|HGNC=|MCL_coexpression_id=42|UniProt=Q9JHG0|association_with_transcript=0bp_to_ENSMUST00000063871,NM_019820,uc007uba.1_5end|description=CAGE_peak_6_at_Cbln3_5end|id=chr14:56503087..56503092,-|ontology_enrichment_celltype=CL:0002614!4.17e-07!3|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002037!1.16e-18!4;UBERON:0002680!1.16e-18!4;UBERON:0001895!1.16e-18!4;UBERON:0010092!1.16e-18!4;UBERON:0006215!1.16e-18!4;UBERON:0004733!8.26e-13!6;UBERON:0004732!8.26e-13!6;UBERON:0002028!8.26e-13!6;UBERON:0007277!8.26e-13!6;UBERON:0002038!4.17e-07!3;UBERON:0002308!4.17e-07!3;UBERON:0009663!4.17e-07!3;UBERON:0009661!4.17e-07!3;UBERON:0006331!4.17e-07!3;UBERON:0000125!4.17e-07!3;UBERON:0003076!6.76e-07!12;UBERON:0003057!6.76e-07!12|ontology_enrichment_uberon_v019_2=UBERON:0002037,6.52e-23,4;UBERON:0002680,6.52e-23,4;UBERON:0001895,6.52e-23,4;UBERON:0010092,6.52e-23,4;UBERON:0006215,6.52e-23,4;UBERON:0004733,8.02e-16,6;UBERON:0004732,8.02e-16,6;UBERON:0002028,8.02e-16,6;UBERON:0007277,8.02e-16,6;UBERON:0003076,1.13e-08,12;UBERON:0003057,1.13e-08,12|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17008658030214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.837548997004143,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.878342391034642,7.12118803165747,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p6@Cbln3}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:56410 | |||
|HGNC= | |||
|MCL_coexpression_id=42 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:Q9JHG0 | |||
|association_with_transcript=0bp_to_ENSMUST00000063871,NM_019820,uc007uba.1_5end | |||
|cluster_id=chr14:56503087..56503092,- | |||
|description=CAGE_peak_6_at_Cbln3_5end | |||
|id=chr14:56503087..56503092,- | |||
|ontology_enrichment_celltype=CL:0002614!4.17e-07!3 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002037!1.16e-18!4;UBERON:0002680!1.16e-18!4;UBERON:0001895!1.16e-18!4;UBERON:0010092!1.16e-18!4;UBERON:0006215!1.16e-18!4;UBERON:0004733!8.26e-13!6;UBERON:0004732!8.26e-13!6;UBERON:0002028!8.26e-13!6;UBERON:0007277!8.26e-13!6;UBERON:0002038!4.17e-07!3;UBERON:0002308!4.17e-07!3;UBERON:0009663!4.17e-07!3;UBERON:0009661!4.17e-07!3;UBERON:0006331!4.17e-07!3;UBERON:0000125!4.17e-07!3;UBERON:0003076!6.76e-07!12;UBERON:0003057!6.76e-07!12 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002037,6.52e-23,4;UBERON:0002680,6.52e-23,4;UBERON:0001895,6.52e-23,4;UBERON:0010092,6.52e-23,4;UBERON:0006215,6.52e-23,4;UBERON:0004733,8.02e-16,6;UBERON:0004732,8.02e-16,6;UBERON:0002028,8.02e-16,6;UBERON:0007277,8.02e-16,6;UBERON:0003076,1.13e-08,12;UBERON:0003057,1.13e-08,12 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17008658030214,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.837548997004143,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.878342391034642,7.12118803165747,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p6@Cbln3 | |||
}} |
Revision as of 13:08, 4 August 2015
Short description: | p6@Cbln3 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_6_at_Cbln3_5end |
Coexpression cluster: | MCL_coexpression_mm9:42 |
Association with transcript: | 0bp_to_ENSMUST00000063871, NM_019820, uc007uba.1_5end |
EntrezGene: | 56410 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cerebellum | 6.52e-23 | 4 |
regional part of metencephalon | 6.52e-23 | 4 |
metencephalon | 6.52e-23 | 4 |
future metencephalon | 6.52e-23 | 4 |
rhombic lip | 6.52e-23 | 4 |
segmental subdivision of hindbrain | 8.02e-16 | 6 |
segmental subdivision of nervous system | 8.02e-16 | 6 |
hindbrain | 8.02e-16 | 6 |
presumptive hindbrain | 8.02e-16 | 6 |
posterior neural tube | 1.13e-08 | 12 |
chordal neural plate | 1.13e-08 | 12 |